Skip to content

Clinical trials

Essential Hypertension trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Country / region: China Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20063
20071
20081
20091
20103
20111
20123
20137
20142
20154
20163
20171
20182
20192
20203
20218
20225
20236
20248
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Unknown status25
Recruiting11
Not yet recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Shenzhen Salubris Pharmaceuticals Co., Ltd.5
Shenzhen Ausa Pharmed Co.,Ltd3
The Second Affiliated Hospital of Chongqing Medical University3
Yi Yang3
Beijing Chao Yang Hospital2
Chinese Academy of Medical Sciences, Fuwai Hospital2
Daiichi Sankyo2
Jiangxi University of Traditional Chinese Medicine2
Shanghai Pharmaceuticals Holding Co., Ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension73
Hypertension19
Cardiovascular Diseases3
Diabetes Mellitus, Type 22
Hyperaldosteronism2
Acute Coronary Syndrome1
Adrenocortical Adenoma1
Atrial Fibrillation1
Coronary Disease1
Cytomegalovirus Infections1

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.